Beyond Bacterial Lysis: Uncovering the Immunological Dimensions of Phage Therapy

  • Drawing on two decades of clinical experience and over 800 treated patients at Europe’s first phage therapy centre, explore how therapeutic phages interact with the human immune system beyond their antibacterial activity
  • Examining emerging data on the immunomodulatory and anti-inflammatory potential of phages, and how these mechanisms may open new therapeutic avenues for immune-mediated and chronic conditions
  • Discussing how insights from patient treatment and immunological studies can inform regulatory dialogue, trial design and potency assessment, helping define safe and effective phage medicinal products for human use